<p>在當前市場交易中，<strong>吉利德科學公司 (NASDAQ: GILD)</strong> 的股價為 147.00 美元，下降了 <strong>1.31%</strong>。然而，在過去一個月中，該公司的股價上漲了 <strong>4.93%</strong>，在過去一年中上漲了 <strong>28.42%</strong>。股東可能會對股票是否被高估感興趣，即使該公司在當前交易中的表現不盡如人意。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="過去一年圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_0.png"/></p>
<h3>評估吉利德科學的市盈率與同行的比較</h3>
<p>市盈率是長期股東用來評估公司市場表現的工具，通常與整體市場數據、歷史收益和行業整體情況進行比較。較低的市盈率可能表明股東不期望該股票在未來表現更好，或者可能意味着公司被低估。</p>
<p>吉利德科學的市盈率低於生物技術行業整體市盈率 <strong>79.25</strong>。理想情況下，人們可能會認為該股票的表現會遜色於同行，但也有可能該股票被低估。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="儀表" width="700" height="500" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_1.png"/></p>
<p>總之，儘管市盈率是投資者評估公司市場表現的有價值工具，但使用時應謹慎。低市盈率可能表明被低估，但也可能暗示增長前景疲弱或財務不穩定。此外，市盈率只是投資者在做出投資決策時應考慮的眾多指標之一，應該與其他財務比率、行業趨勢和定性因素一起評估。通過全面分析公司的財務健康狀況，投資者可以做出更明智的決策，從而更有可能獲得成功的結果。</p>

吉利德科學

<p>吉利德科學（Gilead Sciences Inc.，NASDAQ:GILD）股票目前價格為 147.00 美元，反映出下降 1.31%。儘管如此，該股票在過去一個月上漲了 4.93%，在過去一年上漲了 28.42%。公司的市盈率低於生物技術行業的平均水平 79.25，這表明可能被低估。然而，低市盈率也可能表明增長前景疲弱。投資者在做出投資決策之前，應考慮多個財務指標和定性因素，以進行全面分析</p>

<p>In the current market session, <strong>Gilead Sciences Inc. (NASDAQ: GILD)</strong> stock price is at $147.00, after a <strong>1.31%</strong> decrease. However, over the past month, the company's stock increased by <strong>4.93%</strong>, and in the past year, by <strong>28.42%</strong>. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session.</p>
<div class="lb-trans"><p>在當前市場交易中，<strong>吉利德科學公司 (NASDAQ: GILD)</strong> 的股價為 147.00 美元，下降了 <strong>1.31%</strong>。然而，在過去一個月中，該公司的股價上漲了 <strong>4.93%</strong>，在過去一年中上漲了 <strong>28.42%</strong>。股東可能會對股票是否被高估感興趣，即使該公司在當前交易中的表現不盡如人意。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_0.png" alt="Past Year Chart" original-src="https://www.benzinga.com/files/images/story/2026/1772229633_0.png"/></p>
<h3>Evaluating Gilead Sciences P/E in Comparison to Its Peers</h3>
<div class="lb-trans"><h3>評估吉利德科學的市盈率與同行的比較</h3>
</div><p>The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued.</p>
<div class="lb-trans"><p>市盈率是長期股東用來評估公司市場表現的工具，通常與整體市場數據、歷史收益和行業整體情況進行比較。較低的市盈率可能表明股東不期望該股票在未來表現更好，或者可能意味着公司被低估。</p>
</div><p>Gilead Sciences has a lower P/E than the aggregate P/E of <strong>79.25</strong> of the Biotechnology industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued.</p>
<div class="lb-trans"><p>吉利德科學的市盈率低於生物技術行業整體市盈率 <strong>79.25</strong>。理想情況下，人們可能會認為該股票的表現會遜色於同行，但也有可能該股票被低估。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772229633_1.png" alt="Guage" original-src="https://www.benzinga.com/files/images/story/2026/1772229633_1.png"/></p>
<p>In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.</p>
<div class="lb-trans"><p>總之，儘管市盈率是投資者評估公司市場表現的有價值工具，但使用時應謹慎。低市盈率可能表明被低估，但也可能暗示增長前景疲弱或財務不穩定。此外，市盈率只是投資者在做出投資決策時應考慮的眾多指標之一，應該與其他財務比率、行業趨勢和定性因素一起評估。通過全面分析公司的財務健康狀況，投資者可以做出更明智的決策，從而更有可能獲得成功的結果。</p>
</div>

吉利德科學的市盈率分析